A total of 199 strains of shigella (1 Shigella dysenteriae, 15 S. boydii, 47 S. flexneri, and 136 S. sonnei) isolated in Malmo, Sweden, within a 3-year period (1977 through January 1980) were tested with the agar plate dilution method for susceptibility to commonly used and newer antimicrobial agents. Mecillinam, nalidixic acid, and trimethoprim had the best in vitro activity. S. flexneri dominated among strains resistant to three or more antimicrobial agents and were less susceptible to ampicillin, chloramphenicol, and doxycycline than other types studied. Sixty-four percent of the strains were resistant to sulfamethoxazole. In vitro, a synergistic effect with trimethoprim was shown only in strains susceptible to sulfamethoxazole. The amidinopenicillin mecillinam was highly active against shigellae. When resistance occurred, it was linked to ampicillin in 17 of 18 Susceptibility testing. The inoculum was derived from a 24-h culture of shigella grown on lactose-saccharose urea agar (9) . Three to five colonies were transferred into a broth containing 0.5% beef extract (Difco Laboratories, Detroit, Mich.) 1% peptone, 0.1% glucose, 0.3% sodium chloride, and 0.2% sodium biphosphate in distilled water and incubated overnight at 37°C. The (5) and by Haltalin and Nelson of 60% in 1965 (7) . In spite of the resistance to sulfamethoxazole, several authors have described high susceptibility to the trimethoprim-sulfamethoxazole combination in vitro (1, 3, 5) and good clinical results (3). We believe that the efficacy of the trimethoprim-sulfamethoxazole combination in shigellosis is ascribable to trimethoprim alone in infections with sulfamethoxazole-resistant strains. The possible synergism between trimethoprim and sulfamethoxazole in shigella has been thoroughly examined by Jarvis and Scrimgeour (8) and Grimnm (6) , and, like us, none of these authors has found any synergistic effect in the The rather uniform patterns of multiple resistance in our strains imply that the resistance probably is R-factor mediated. The linked resistance pattern between beta-lactam antibiotics is perhaps influenced by production of beta-lactamase.
The quinoline drugs are apparently not involved in plasmid-mediated transfer of antimicrobial resistance (2) , which gives them a special advantage. As early as 1965, Moorhead and Parry concluded that nalidixic acid was a useful alternative in the treatment of Sonne dysentery (10) . Our own experiences with nalidixic acid at 4 g daily for 7 days have been satisfactory in eradicating shigella from the stool in shigellosis and shigella carriers (Hansson et al., in press).
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